Testing effectiveness (Phase 2)Looking for participantsNCT06176989
What this trial is testing
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Who this might be right for
Metastatic ChondrosarcomaLocally Advanced ChondrosarcomaMetastatic Sinonasal Adenocarcinoma+7 more
National Cancer Institute (NCI) 40